$2.96
0.155.16%
Last update: Nov 6, 3:20 PM

The average analyst price target for Coya Therapeutics is $15.57, 426.9% above the current price. Of 7 analysts, 7 rate it Buy. Targets range from $12 to $18. The latest change came on Jun 5, 2026, when Roth Capital initiated coverage of Coya Therapeutics with a Buy rating and a $12 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months